Home/Filings/4/0001628280-20-013109
4//SEC Filing

SAFWAT NEDAL 4

Accession 0001628280-20-013109

CIK 0000727207other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 3:05 PM ET

Size

10.3 KB

Accession

0001628280-20-013109

Insider Transaction Report

Form 4
Period: 2020-08-17
SAFWAT NEDAL
Chief Strategy Officer
Transactions
  • Award

    Employee Restricted Stock Units

    2020-08-17+30,00030,000 total
    Common Stock (30,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2020-08-17+100,000100,000 total
    Exercise: $14.51Exp: 2030-08-17Common Stock (100,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2020-08-17+39,769139,769 total
    Exercise: $14.51Exp: 2030-08-17Common Stock (39,769 underlying)
Footnotes (5)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The reporting person received restricted stock units on August 17, 2020, which vest in 3 equal installments over 3 years, with the first installment vesting on August 17, 2021. Upon vesting, the reportingperson will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
  • [F3]Not Applicable.
  • [F4]Options shall vest and become exercisable each year for 3 years, with the first installment vesting on August 17, 2021.
  • [F5]Options shall vest and become exercisable each year for 5 years, with the first installment vesting on August 17, 2021.

Issuer

Accelerate Diagnostics, Inc

CIK 0000727207

Entity typeother

Related Parties

1
  • filerCIK 0001822858

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 3:05 PM ET
Size
10.3 KB